Effect of different fixative solutions on eyes with experimental proliferative vitreoretinopathy

E-ISSN： 1365-2613|96|2|103-110

ISSN： 0959-9673

Source： INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (ELECTRONIC), Vol.96, Iss.2, 2015-04, pp. : 103-110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of caffeic acid phenethyl ester and cortisone may prevent proliferative vitreoretinopathy

By Yusuf Turkoz Hamdi Er Mehmet Borazan Harun Y

Mediators of Inflammation, Vol. 13, Iss. 2, 2004-04 ,pp. : 127-130

Informa Healthcare

Access to resources Recommend Favorite

Defining the seriousness of proliferative vitreoretinopathy by aspiration of cytokines from the anterior chamber

By Rusnak Stepan Vrzalova Jindra Hecová Lenka Kozova Marketa Topolcan Ondrej Ricarova Renata

Biomarkers in Medicine, Vol. 7, Iss. 5, 2013-10 ,pp. : 759-767

Future Medicine

Access to resources Recommend Favorite

Chemokine CXCL‐1: activity in the vitreous during proliferative vitreoretinopathy

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 181, Iss. 2, 2015-08 ,pp. : 338-342

John Wiley & Sons Inc

Access to resources Recommend Favorite

Postoperative aqueous humour flare as a surrogate marker for proliferative vitreoretinopathy development

ACTA OPHTHALMOLOGICA, Vol. 96, Iss. 2, 2018-03 ,pp. : 192-196

John Wiley & Sons Inc

Access to resources Recommend Favorite

Eyes

DIABETIC MEDICINE, Vol. 16, Iss. S1, 1999-05 ,pp. : 66-66

John Wiley & Sons Inc

Access to resources Recommend Favorite